[Federal Register: July 25, 2001 (Volume 66, Number 143)]
[Notices]
[Page 38707-38708]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25jy01-106]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 01143]
HIV/AIDS Surveillance, Prevention and Medical Support and
Treatment in the Socialist Republic of Vietnam; Notice of Availability
of Funds
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2001 funds for a cooperative agreement
with the Vietnam Ministry of Health's (MOH) National AIDS Standing
Bureau (NASB) for improvement, expansion and evaluation of HIV/AIDS
and, as relevant, other emerging infections surveillance, prevention
and medical support and treatment in Vietnam.
The United States Government (USG) seeks to reduce the impact of
HIV/AIDS in specific countries with sub-Saharan Africa, Asia and the
Americas through its Leadership and Investment in Fighting an Epidemic
(LIFE) initiative. To carry out this initiative, CDC has organized its
Global AIDS Program (GAP) to strengthen capacity and expand activities
in the areas of (1) HIV prevention; (2) HIV care, support and
treatment; and (3) capacity and infrastructure development, especially
for HIV/AIDS surveillance activities.
Targeted countries represent those with the most severe epidemics
and the highest number of new infections. They also represent countries
where the potential for impact is greatest and where U.S. Government
agencies are already active. Vietnam is one of these targeted
countries.
As a key partner in the USG LIFE Initiative, CDC is working in a
collaborative manner with national governments and other agencies to
develop programs of assistance to address the HIV/AIDS epidemics in
LIFE Initiative countries. In particular, CDC's mission in Vietnam is
to strengthen and make more effective the HIV prevention and medical
support and treatment efforts to prevent HIV infection and associated
illness and death from AIDS. CDC is also planning to increase its
support for assessment and research efforts in Vietnam for tuberculosis
(TB), sexually transmitted infections (STI) and other emerging
infections.
B. Eligible Applicants
Assistance will be provided only to the MOH, which will provide the
funding to the NASB or other designated agency depending on the program
goal (e.g., NITBRP, NIDV, NIHE, etc.). The MOH and its agencies are the
only appropriate and qualified organizations to conduct a specific set
of activities supportive of the CDC Global AIDS Program and its
emerging diseases program in Vietnam because:
1. The MOH is uniquely positioned, in terms of legal authority and
credibility among Vietnamese citizens, to collect crucial data on HIV/
AIDS prevalence and incidence, as well as other health information,
among Vietnamese citizens.
2. The MOH already has established mechanisms to access health
information, enabling it to immediately become engaged in the
activities listed in this announcement.
3. The purpose of this announcement is to build upon the existing
framework of health information and activities that the MOH itself has
collected or initiated.
4. The MOH has been mandated by the National Assembly of Vietnam to
coordinate and implement activities necessary for the control of
epidemics, including HIV/AIDS, TB, STI and other emerging infections.
C. Availability of Funds
Approximately $2,250,000 is available in 2001 to fund this
agreement. Of the $2,250,000, approximately $2,000,000 will be for HIV/
AIDS and approximately $250,000 for TB and emerging infections. It is
expected that the awards will begin on or about September 30, 2001 and
will be made for a 12-month budget period within a project period of
five years. Annual funding estimates may change. Continuation of awards
within the approved project period will be made on the basis of
satisfactory progress as evidenced by required reports and the
availability of funds.
Use of Funds
Antiretroviral Drugs
Funds received from this announcement will not be used for the
purchase of antiretroviral drugs for treatment of established HIV
infection (with the exception nevirapine in PMTCT cases and with prior
written approval), occupational exposures, and non-occupational
exposures and will not be used for the purchase of machines and
reagents to conduct the necessary laboratory monitoring for patient
care.
Applicants may contract with other organizations under these
cooperative agreements, however, applicants must perform a substantial
portion of the
[[Page 38708]]
activities (including program management and operations and delivery of
prevention services for which funds are requested.
The costs that are generally allowable in grants to domestic
organizations are likewise allowable to foreign institutions and
international organizations, with the following exceptions:
Indirect Costs: With the exception of the American University,
Beirut, the Gorgas Memorial Institute, and the World Health
Organization, indirect costs will not be paid (either directly or
through a sub-award) to organizations located outside the territorial
limits of the United States or to international organizations
regardless of their location.
All requests for funds, including the budget contained in the
application, shall be stated in U.S. dollars. Once an award is made,
the Department of Health and Human Services (DHHS) will not compensate
foreign grantees for currency exchange fluctuations through the
issuance of supplemental awards.
Needle Exchange
No funds appropriated under this Act shall be used to carry out any
program of distributing sterile needles or syringes for the hypodermic
injection of any illegal drug.
D. Where To Obtain Additional Information
This and other CDC announcements can found on the CDC home page
internet address--http://www.cdc.gov. Click on ``Funding'' then
``Grants and Cooperative Agreements.''
If you have any questions after reviewing the contents of all the
documents, business management technical assistance may be obtained
from: Dorimar Rosado, Grants Management Specialist, Grants Management
Branch, Procurement and Grants Office, Centers for Disease Control and
Prevention, Room 3000, 2920 Brandywine Road, Atlanta, GA 30341-4146,
Telephone: (770)-488-2782, E-mail: dpr7@cdc.gov.
For program technical assistance, contact: Gary West, MPA, Deputy
Director, Global AIDS Program, National Center for HIV, STD and TB
Prevention, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, Mailstop E-41, Telephone: (404) 639-4268 E-mail:
Gwest@cdc.gov
Dated: July 19, 2001.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 01-18465 Filed 7-24-01; 8:45 am]
BILLING CODE 4163-18-P